Emyria Ltd completes $2.5M placement to advance MDMA and psilocybin assisted therapy
Emyria Ltd (ASX:EMD) has received firm commitments from sophisticated and strategic investors in a well-supported $2.5 million placement at an offer price...
Source: proactiveinvestors.com.au